Eli Lilly and Co
(MIL:1LLY)
€
1,037.4
-22.4 (-2.11%)
Market Cap: 930.72 Bil
Enterprise Value: 964.17 Bil
PE Ratio: 42.22
PB Ratio: 34.04
GF Score: 76/100 
Eli Lilly and Co at Evercore ISI HealthCONx Virtual Conference Transcript
Nov 30, 2021 / 05:10PM GMT
Umer Raffat
Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research
Thank you guys for joining us. Pleasure to have Dan from Lilly management, an R&D organization, join us. I feel like it's become a bit of an annual tradition and maybe Dan's the only one to raise his hand to agreeing to do this every year, but I apologize in advance, Dan.
Daniel M. Skovronsky
Eli Lilly and Company - Senior VP, Chief Scientific Officer & President of Lilly Research Labs
Thanks for that. I didn't know I [cursed you], Umer. I thought this was a part of my job.
Questions & Answers
Umer Raffat
Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research
Fantastic. Well, I feel like we should start today with a topic that you guys never get questions on, which is Alzheimer's. And maybe perhaps -- actually, even before that, Dan, let me turn it over to you first. Maybe lay out the top R&D priorities from your
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers